Fletcher Spaght Revenue and Competitors
Estimated Revenue & Valuation
- Fletcher Spaght's estimated annual revenue is currently $6M per year.
- Fletcher Spaght's estimated revenue per employee is $187,000
Employee Data
- Fletcher Spaght has 32 Employees.
- Fletcher Spaght grew their employee count by 0% last year.
Fletcher Spaght's People
Name | Title | Email/Phone |
---|---|---|
1 | SVP | Reveal Email/Phone |
2 | SVP | Reveal Email/Phone |
3 | Partner | Reveal Email/Phone |
4 | Partner | Reveal Email/Phone |
5 | Executive Assistant | Reveal Email/Phone |
6 | Managing Partner | Reveal Email/Phone |
7 | Associate Consultant | Reveal Email/Phone |
Fletcher Spaght Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $58.3M | 241 | 20% | N/A | N/A |
#2 | $924.6M | 3002 | -1% | N/A | N/A |
#3 | $16.9M | 77 | 45% | N/A | N/A |
#4 | $19.4M | 88 | 1% | N/A | N/A |
#5 | $72.6M | 300 | 3% | N/A | N/A |
#6 | $7.6M | 43 | 8% | N/A | N/A |
#7 | $3.7M | 24 | -17% | N/A | N/A |
#8 | $39.2M | 162 | 9% | N/A | N/A |
#9 | $3.7M | 24 | 4% | N/A | N/A |
#10 | $30.4M | 138 | N/A | N/A | N/A |
What Is Fletcher Spaght?
Fletcher Spaght Ventures, L.P. (FSV) is a venture capital fund investing in emerging growth high technology and healthcare companies. Established to build substantial, long-term capital appreciation, FSV invests in companies with: Familiarity/experience with the company. Promising business potential. Financing led by top-tier venture capital firm. Included are companies in the areas of information technology (IT) and IT services, Internet, software, telecommunications, medical devices, healthcare informatics, biotechnology and healthcare services.
keywords:N/AN/A
Total Funding
32
Number of Employees
$6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Fletcher Spaght News
Share Share on Facebook Share on Twitter LinkedIn Email Reprints Here’s a look at news from around Southeast Michigan’s innovation community: —Ann Arbor-based Swift Biosciences announced this week that it has raised a $7 million Series B round. Fletcher Spaght Ventures led the round, and the R ...
Swift Biosciences, an Ann Arbor, Michigan-based developer of technologies for genomics and personalized medicine, raised $7m in Series B financing. The round was led by Fletcher Spaght Ventures with participation from Renaissance Venture Capital Fund, the Mercury Fund, Michigan Accelerator Fund ...
The biotechnology firm raised $48.4 million earlier this year in its third tranche for its series B financing round led by New Enterprise Associates with participation by Hatteras Venture Partners, Johnson & Johnson Development Corp., Astellas Venture Management and Fletcher Spaght Ventures. Th ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.3M | 32 | -32% | N/A |
#2 | $3.3M | 32 | -24% | N/A |
#3 | $8.3M | 32 | 0% | N/A |
#4 | $4.2M | 32 | 3% | N/A |
#5 | $3.5M | 32 | 23% | $14M |